Cullinan Therapeutics, Inc. (CGEM)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
21. 79
-0.28
-1.2687%
$
1.36B Market Cap
- P/E Ratio
- Div Yield
546,139 Volume
- Eps
$ 22.07
Previous Close 
Want to track CGEM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cullinan Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Robert Driscoll Wedbush | 1,229.56 | $27,788.13 | $27,136.47 | -$651.66 | -2.35% |
